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n Vivo 18F-Fluorodeoxyglucose
ositron Emission Tomography
maging Provides a Noninvasive Measure
f Carotid Plaque Inflammation in Patients
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homas J. Brady, MD,† and Alan J. Fischman, MD, PHD†
oston, Massachusetts
OBJECTIVES Given the importance of inflammation in atherosclerosis, we sought to determine if
atherosclerotic plaque inflammation could be measured noninvasively in humans using
positron emission tomography (PET).
BACKGROUND Earlier PET studies using fluorodeoxyglucose (FDG) demonstrated increased FDG uptake in
atherosclerotic plaques. Here we tested the ability of FDG-PET to measure carotid plaque
inflammation in patients who subsequently underwent carotid endarterectomy (CEA).
METHODS Seventeen patients with severe carotid stenoses underwent FDG-PET imaging 3 h after
FDG administration (13 to 25 mCi), after which carotid plaque FDG uptake was determined
as the ratio of plaque to blood activity (target to background ratio, TBR). Less than 1 month
after imaging, subjects underwent CEA, after which carotid specimens were processed to
identify macrophages (staining with anti-CD68 antibodies).
RESULTS There was a significant correlation between the PET signal from the carotid plaques and the
macrophage staining from the corresponding histologic sections (r  0.70; p  0.0001).
When mean FDG uptake (mean TBR) was compared with mean inflammation (mean
percentage CD68 staining) for each of the 17 patients, the correlation was even stronger (r 
0.85; p  0.0001). Fluorodeoxyglucose uptake did not correlate with plaque area, plaque
thickness, or area of smooth muscle cell staining.
CONCLUSIONS We established that FDG-PET imaging can be used to assess the severity of inflammation
in carotid plaques in patients. If subsequent natural history studies link increased FDG-PET
activity in carotid arteries with clinical events, this noninvasive measure could be used to
identify a subset of patients with carotid atherosclerosis in need of intensified medical therapy
or carotid artery intervention to prevent stroke. (J Am Coll Cardiol 2006;48:1818–24)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.05.076© 2006 by the American College of Cardiology Foundation
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iurrent management of carotid atherosclerotic disease is
uided primarily by determination of degree of carotid
rtery stenosis and does not take advantage of imaging
echniques that could provide information about plaque
omposition and biological activity. Among the targets for
maging, detection of inflammation is likely to be of value
ecause of the well-documented association between in-
ammatory processes and plaque rupture (1–6). A nonin-
asive method to characterize inflammation in carotid
laques may be of value for determination of prognosis,
election of appropriate medical or surgical therapy, and
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ular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston,
assachusetts. Supported in part by grants from NIH (RR16046) and the Center for
ntegration of Medicine and Innovative Technologies and by unrestricted research
rants from Pfizer and GlaxoSmithKline.i
Manuscript received July 27, 2005; revised manuscript received April 27, 2006,
ccepted May 2, 2006.ssessment of novel therapies designed to stabilize athero-
clerotic plaques.
Preliminary data from our group and others have
emonstrated that positron emission tomography (PET)
ith 18F-fluorodeoxyglucose (FDG) can identify in-
amed atherosclerotic plaques in an animal model of
therosclerosis (7–9). Furthermore, Rudd et al. (10,11)
emonstrated increased carotid uptake of FDG in pa-
ients with evidence of a recent ischemic cerebrovascular
vent. The same group demonstrated in ex vivo experi-
ents that FDG co-localizes with macrophages within
xcised carotid specimens that are incubated with FDG
10). However, that ex vivo experiment used quantities of
DG that cannot be used in vivo in patients. Moreover,
lthough it is evident that symptomatic vascular lesions
an be detected using FDG-PET, it remains unknown if
he imaging technique can be used to noninvasively character-
ze the severity of vascular inflammation in patients. Accord-
ngly, in this study, we tested the hypothesis that inflammation
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November 7, 2006:1818–24 FDG-PET Measures Vascular Inflammation in Humansn human carotid arteries could be measured noninvasively, in
ivo, using 18FDG-PET.
ETHODS
atients. Seventeen adult patients (11 men, 6 women) with
evere carotid artery stenosis already scheduled to undergo
arotid endarterectomy (CEA) were recruited. Eligibility
riteria included a 70% to 99% stenosis of the internal
arotid artery detected by carotid Doppler ultrasound, mag-
etic resonance angiography, or computed tomography an-
iography. All patients were expected to undergo CEA within
month of enrollment. The study protocol was approved by
he local Human Research Committee, and informed con-
ent was obtained from each subject.
ET imaging. FDG was administered (13 to 25 mCi)
ntravenously after an overnight fast. Three hours later,
maging was performed using a Siemens ECAT Exact
R system (Siemans, Knoxville, Tennessee), which pro-
ides 63 planes, a 15.5-cm field of view, and 4.2-mm
ntrinsic resolution. Data were acquired in 3-dimensional
ode. The choice of time interval was based on our previous
ork in animals and on the work of Rudd et al. (10).
atients were imaged in the supine position using a head
xation device. Images were obtained over 20 min.
ttenuation-corrected images were reconstructed using a
anning filter with a conventional, filtered back-projection
lgorithm, yielding an effective resolution of 5 mm.
natomic imaging, image co-registration, and measure-
ent of FDG uptake. Metabolic imaging with PET
rovides limited structural data. Accordingly, anatomic im-
ging with either multidetector computed tomographic
maging (MDCT) (n  11 patients) or magnetic resonance
maging (MRI) (n  6 patients) was performed using
reviously reported methods (12,13) for structural delinea-
ion of the carotid arteries and their atherosclerotic plaques.
The PET images were co-registered with the structural
MDCT or MRI) images using a workstation that enables
ultimodal standard (rigid) image fusion (REVEAL-
VS; Mirada Solutions, Oxford, United Kingdom). The
ET and CT (or MR) images were manually co-registered
y an investigator blinded to the histologic analysis using
xtravascular anatomic landmarks (such as brain, spinal
ord, spine, and jaw) that were apparent on both images.
After co-registration of the images, carotid FDG uptake
as measured along the length of the carotid vessel, starting
Abbreviations and Acronyms
CEA  carotid endarterectomy
FDG  18F-fluorodeoxyglucose
hsCRP  high-sensitivity C-reactive protein
PET  positron emission tomography
SUV  standardized uptake value
TBR  target-to-background ratiot the bifurcation and extending inferiorly and superiorly overy 4 mm. Because the length of carotid plaque that would
ventually be removed during endarterectomy was not
nown at the time of image analysis, the measurements were
xtended, at 4-mm intervals, to points 4 cm above and 2 cm
elow the carotid bifurcation. However, only those sections
or which carotid histology was eventually obtained were
sed for analysis. At each axial plane along the length of the
arotid, regions of interest (ROIs) (approximately 8 mm in
iameter) were placed within the wall of the carotid vessel
or determination of the standardized uptake value (SUV).
he SUV is the decay-corrected tissue concentration of
DG (in kBq/ml) divided by the injected dose per body
eight (kBq/g). The CT and MRI data were used to guide
lacement of the ROI within the plaque (area of greatest
all thickening) at each axial plane. In cases where the
laque occupied more than 180° of the vessel wall the SUV
easurement was taken at the most metabolically active half
f the vessel wall. To obtain a background value for FDG
ptake, SUV was measured in a venous structure. To
ccomplish this, an ROI was placed within the center of a
arge vein (such as the subclavian or internal jugular vein) in
n area devoid of significant spill-over activity. Afterward, a
arget-to-background ratio (TBR) was calculated as carotid
laque SUV divided by venous blood SUV, and an averaged
alue of TBR was calculated for each patient (mean TBR).
dditionally, we calculated the plaque-to-blood SUV gra-
ient as the difference between the carotid plaque SUVs and
lood background SUV (SUV).
Blinding was maintained between investigators responsi-
le for the registration of PET and structural images, and
he determination of PET uptake, on the one hand, and
hose responsible for the histologic analyses of the CEA
pecimens, on the other hand. To determine the variability
f the measurement (mean plaque TBR), images from 10
atients were twice co-registered and analyzed, several
eeks apart in a blinded manner. The mean ( SD) intraob-
erver difference was 8.9  9.0%.
istology and immunohistochemistry. At the time of
EA, the atherosclerotic plaques were immediately fixed in
0% buffered formalin and subsequently decalcified in the
tandard fashion. Specimens were transversely sectioned at
-mm intervals. Each interval section was embedded face up
n paraffin and cut at 5-m thickness to yield 4 slices for
ubsequent staining. For immunohistochemistry, sections
ere mounted on gelatin-coated slides and subsequently
tained with a macrophage-specific, anti-CD68 monoclonal
ntibody (mAb KP-1; Dako, Glostrup, Denmark) and a
mooth muscle cell-specific antibody (anti-smooth muscle cell
lpha-actin antibody; Dako).
Assessment of macrophage and smooth muscle cell stain-
ng was performed using the methods of Jander et al. (14).
omputer-assisted planimetry was used to quantitate areas
f staining. The sections were computerized as color-
ncoded digitized images (Sony CCD camera, Hamamatsu
VS video image processing unit, and National Institutes
f Health image analyzing software on an Apple Macintosh
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FDG-PET Measures Vascular Inflammation in Humans November 7, 2006:1818–24ersonal computer). Total section areas and areas of mac-
ophage infiltration were outlined manually by comparing
he computerized image with the microscopic image at 4
nd 20 magnification. Macrophage staining was deter-
ined at each carotid slice and reported as the absolute area
taining for macrophages (mm2) at each carotid level.
dditionally, inflammation was recorded as percentage of
laque staining. In cases where the plaque occupied more
han 180° of the vessel wall, the value for percentage
laque staining in the most inflamed half of the vessel
all (% CD68 staining) was reported. This was done for
mproved registration with the imaging findings, because
he imaging values were derived from the most metaboli-
ally active half of the vessel wall at each axial section of the
ET images. Smooth muscle cell staining was defined as
he percentage of plaque staining for antismooth muscle cell
ntibody. Morphometric measurement of lipid area, cap
hickness, and collagen content were performed.
o-registration and comparison of histologic and PET
ata. The axial PET images were registered to histology
ections on the basis of the distance from the common
arotid bifurcation. The carotid bifurcation was defined as
he apex of the luminal flow divider (which divides internal
nd external carotid artery) as identified on the CT (or MR)
mages as well as the pathologic specimens. Contraction
due to axial elastic recoil) of the endarterectomy specimen
uring histologic processing (between its relatively stretched
tate in vivo to a more contracted state ex vivo) was
bserved. To account for this change in tissue length, 25%
ontraction in the length of the specimens along the
nferior-superior dimension was assumed, based on earlier
xperience of the lab.
igh-sensitivity C-reactive protein. Serum high-
ensitivity C-reactive protein (hsCRP) was measured using
n automatic immunonephelometer with a sensitivity of
.02 mg/dl (Behring, Deerfield, Illinois).
tatistical methods. Data were analyzed using SPSS for
indows version 13.0 (SPSS, Inc, Chicago, Illinois).
ontinuous parameters are reported as mean values 
D. Spearman method was used to assess the correlation
etween the 18FDG uptake (FDG TBR) and the his-
opathologic assessment of inflammation (% CD68 stain-
ng), as well as the correlation between mean FDG
ptake (mean TBR) and the serum hsCRP level. A value
f p  0.05 was considered significant. To correct for
ultiple tests, the alpha was adjusted using the Bonfer-
oni method.
ESULTS
atient characteristics. Patient characteristics are dis-
layed in Table 1.
maging and histology. The 17 carotid plaque specimens
btained during the course of the study yielded 107 plaque
ections (7  4 plaque sections/patient) after sectioning.
here was a significant correlation between the PET signal ajudged as the ratio of target to background PET emissions,
BR) and macrophage staining, for both the absolute macro-
hage area (r  0.68; p  0.0001) and the % CD68 staining
f the plaque sections (r 0.70; p 0.0001) (Figs. 1 to 3). A
ignificant but somewhat weaker correlation was observed
etween absolute FDG uptake (absolute SUV) and both
bsolute macrophage area (r  0.49; p  0.0001), and the
CD68 staining (r  0.58; p  0.0001) of the plaque
ections.
A stronger relationship was noted when mean values for
DG uptake (mean TBR) and histologic inflammation
CD68 staining) were generated for each of the 17 patients,
or % CD68 staining, (r  0.85; p  0.0001; Fig. 4) as well
s absolute macrophage area (r  0.76; p  0.0001).
oncordant with those observations, there was a highly
ignificant correlation between the plaque-to-blood SUV
radient (SUV) and plaque inflammation, measured as
ean % CD68 staining (r  0.88; p  0.001) as well as
bsolute macrophage area (r  0.80; p  0.001). In
ontrast, there was no significant correlation between FDG
ptake (mean TBR) and smooth muscle cell staining (r 
.15; p  0.40) (Fig. 5), collagen staining (r  0.48; p 
.11), plaque thickness (r  0.15; p  0.49), or plaque area
r  0.00; p  0.99). There was no correlation between
ither FDG uptake (mean TBR) or plaque inflammation
mean % CD68 staining) and the following variables:
sCRP, age, gender, blood pressure, serum lipids (total
holesterol, low-density lipoprotein cholesterol, high-
ensity lipoprotein cholesterol, or triglycerides), statin use,
resence of diabetes, body mass index, or smoking.
ISCUSSION
he primary finding of this study is that noninvasive PET
maging can be used to assess the degree of inflammation in
arotid atherosclerotic plaques in vivo as documented by
orrelations in patients undergoing CEA.
8FDG uptake in vascular inflammation. Several groups
ave established that inflamed blood vessels have increased
ptake of 18FDG. This 18FDG enhancement by vascular
nflammation has been demonstrated in animal models of
able 1. Subject Characteristics
Characteristic Mean ( SEM)
ge (yrs) 62  6
ender (M/F) 11/6
ymptoms (%) 24
iabetes (%) 24
moking (%) 29
tatin Rx (%) 65
spirin Rx (%) 100
BP (mm Hg) 137  4
BP (mm Hg) 68  3
DL cholesterol (mg/dl) 96  9
RP (mg/l) 3.6  1.5
RP  C-reactive protein; DBP  diastolic blood pressure; LDL  low-density
ipoprotein; Rx  therapy; SBP  systolic blood pressure.therosclerosis (15) and verified in human studies of patients
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November 7, 2006:1818–24 FDG-PET Measures Vascular Inflammation in Humansith Takayasu’s arteritis, giant cell arteritis, polymyalgia
heumatica, and nonspecific aortitis (16–19). More recently,
8FDG uptake was shown to be greater in carotid plaques
btained from patients with clinical evidence of carotid
laque instability (10). However, in that study, the relation-
hip between inflammation and imaging findings was not
stablished.
The present study for the first time demonstrates that FDG
ptake, determined noninvasively with PET, correlates
trongly with the degree of plaque inflammation. Accordingly,
his study provides histologic validation in humans that carotid
ptake of 18FDG may be useful for noninvasive measurement
f atherosclerotic plaque inflammation.
Several additional, potentially important, observations
ere made. It is apparent that the imaging method enables
he characterization of inflammation within a range of
arotid inflammation that has been shown to be clinically
elevant. The study by Jander et al. (14) previously demon-
trated that carotid plaques from patients with symptomatic
arotid disease are more severely inflamed (18 10% CD68
taining) compared with plaques removed from patients
igure 1. Axial positron emission tomographic (PET) images and the co-re
anifested low 18F-fluorodeoxyglucose (FDG) uptake in the region of th
arotid plaque. The region of the excised carotid plaque is noted with arro
patient A). The corresponding trichrome-stained histologic specimen dem
he high-powered images demonstrates limited macrophage infiltration. Th
linically stable plaque. (B) Carotid plaque specimen taken from the pati
istologic specimen demonstrates a complex plaque with a necrotic core,
istologic features are consistent with a metabolically unstable plaque whiith asymptomatic carotid stenosis (11  4% CD68 stain- tng). Crisby et al. (20) demonstrated that plaques taken
rom symptomatic patients subjected to modest lipid low-
ring (40 mg/day pravastatin for 3 months) are less inflamed
han plaques from patients that did not receive lipid-
owering therapy (15.0  10.2% vs. 25.3  12.5% CD68
taining; p  0.05). Further, others demonstrated that
laques taken from predominantly asymptomatic patients
ubjected to aggressive lipid lowering (80 mg/day atorvasta-
in for 1 month) are less inflamed than plaques from
atients that did not receive lipid-lowering therapy (2.5%
0.1 to 5.2] vs. 9.7 [3.1 to 15.5] % CD68 staining) (21). In
he present study, we analyzed the ability to characterize
laques that fall into groups that bear relevance to the levels
f inflammation shown to be important in the aforemen-
ioned histologic studies (5%, 5% to 15%, and 15%),
nd found a significant difference between the 3 groups,
uggesting that the imaging method may prove useful for
he identification of plaques that may become symptomatic,
nd for following the response to plaque stabilization
trategies such as lipid lowering therapy (Fig. 6).
linical implications. Based on the results of large clinical
ed computed tomographic (CT) images from 2 patients, 1 (patient A) who
tid plaque and 1 (patient B) with high FDG uptake in the region of the
) Carotid plaque specimen taken from the patient with low FDG uptake
ates a collagen-rich plaque with low lipid content, and CD68 staining on
istologic features are consistent with a metabolically stable and potentially
ith high FDG uptake (patient B). The corresponding trichrome-stained
the CD68 staining demonstrates intense macrophage infiltration. These
vulnerable to rupture.gister
e caro
ws. (A
onstr
ese h
ent wrials, carotid revascularization is strongly recommended for
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FDG-PET Measures Vascular Inflammation in Humans November 7, 2006:1818–24ases of severe symptomatic stenoses, whereas for cases of
oderate symptomatic or severe asymptomatic stenoses, the
enefit in terms of stroke risk reduction is modest and
evascularization is often limited to select cases in surgical
enters with high experience (22–24). The findings of the
resent study suggest that PET studies of the carotid
rteries could aid in the risk stratification of patients with
ess stenotic or asymptomatic lesions by identifying inflamed
laques that may be associated with a higher risk of a clinical
vent.
igure 2. Trichrome- (10 magnification) and CD68-stained (200 ma
oxes in the trichrome-stained images indicate the regions corresponding
igure 3. Noninvasive positron emission tomography (PET) measurement
f 18F-fluorodeoxyglucose (FDG) uptake versus macrophage staining. The
ET measurement of carotid plaque FDG uptake (target-to-background
atio [T/B]) in patients was compared with histologic assessment of
nflammation in the corresponding sections taken during carotid endarter-
ctomy. There was a significant correlation between T/B and macrophage
ensity.
c
wThe important role of inflammation in the pathophysi-
logy of atherosclerosis has been well established (1,2). Both
istopathologic and epidemiologic data demonstrate the
rucial role of inflammation in plaque formation and rup-
ure. Plaques that have ruptured are often found to have
xtensive macrophage infiltrates (25–31). The macrophages
re capable of destabilizing plaques by release of enzymes
hich degrade matrix proteins and inhibit collagen forma-
ion. Therefore, the use of 18FDG-PET imaging to char-
ation) carotid specimens that correspond to the images in Figure 1. The
e high-powered CD68 stains. (A and B) As described in Figure 1.
igure 4. Mean within-patient 18F-fluorodeoxyglucose (FDG) uptake
ersus inflammation in carotid endarterectomy patients. For each of the 17
ubjects, all histologic sections were averaged to generate a mean per-
atient value for percentage macrophage staining. Likewise, the corre-
ponding imaging data were combined to generate a mean target-to-
ackground ratio (T/B) for each patient. There was a significant correlation
etween mean T/B and mean inflammation (r  0.85; p  0.001). The
orrelation remained significant (r 0.82; p 0.001) even after the outlier
ith the highest plaque inflammation was removed from the analysis.
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November 7, 2006:1818–24 FDG-PET Measures Vascular Inflammation in Humanscterize plaques according to the degree of inflammation
dds functional to anatomic data and might eventually prove
seful for predicting which patients are at greatest risk of
xperiencing progression of disease or a clinical event. Natural
istory studies will be needed to determine whether such
etabolic imaging will aid in risk assessment.
tudy limitations. A concern regarding this study is that
nflammation is likely to be a dynamic process which can
evelop and regress with time. Therefore, the inflammatory
tate observed on the day of noninvasive imaging may not be
ndicative of the degree of inflammation present on the day
f endarterectomy. To minimize this potential effect, the
ime from imaging to obtaining histologic specimens was
imited to 1 month in the present study. Changes in
nflammation during the interval between imaging and
urgery could have decreased the statistical power of the
tudy. Despite this delay, highly significant correlations
ere observed.
Another concern is that the method for co-registering the
maging and histologic sections is imperfect. There is
otential error in the registration of the PET images with
he histology. Although plaque specimens were carefully
emoved and marked to preserve orientation, several speci-
ens were macerated or fractured, and varying degrees of
ecoil of the specimens was anticipated (perhaps depending
n plaque composition). Such factors could have caused
isregistration between the plaque specimens and images
nd may therefore have reduced the correlation coefficient
etween the individual imaging data and histology. In
nticipation of this potential registration error, we calcu-
ated the average FDG uptake measured for each patient
average TBR for each patient) and compared it with the
verage inflammation seen in all of that patient’s histologic
igure 5. Positron emission tomography (PET) measurement of 18F-
uorodeoxyglucose (FDG) uptake versus smooth muscle cell staining. The
ET measurement of FDG uptake (target-to-background ratio [T/B]) in
atients was compared with histologic assessment of smooth muscle cell
taining (anti-SMA stain) in the corresponding sections taken during
arotid endarterectomy. There was no correlation between FDG uptake
nd smooth muscle cell staining (r  0.15; p  0.54).ections (thereby removing the potential for misregistra-
v
bion). With this approach, the observed correlation was
specially strong (r  0.85; p  0.001)
uture research directions. In addition to the imaging of
xtracardiac vessels, 18FDG may potentially be used to
haracterize coronary arterial plaques. Although small vessel
ize, mobility, and high myocardial uptake of 18FDG
32–34) are potential obstacles to coronary imaging, several
ossible solutions exist. These include techniques to reduce
yocardial uptake of 18FDG and the use of combined
ET-CT cameras to improve localization of tracer activity.
urthermore, novel intravascular positron-sensitive cathe-
ers can detect vascular FDG out of proportion to myocar-
ial FDG, and may develop into a clinically useful imaging
odality. Novel radiopharmaceuticals with greater macro-
hage specificity may further enhance the method.
onclusions. We demonstrated that FDG-PET imaging
an determine macrophage content of carotid plaques in
ivo. This observation has important implications for drug
evelopment and, if supported by natural history studies, for
he clinical care of patients at risk of stroke.
For drug development, this capability can assist in the
linical assessment of pharmaceutical agents designed to
educe macrophage activity in atherosclerotic plaques. It can
o so by identifying patients with macrophage-rich plaques
ho could be randomly assigned to the agent of interest and
y providing a surrogate end point for assessment of
herapeutic efficacy. The direct impact of FDG-PET im-
ging on clinical care would require successful outcome of a
atural history study demonstrating that a positive image
as associated with an increased risk of neurologic symp-
oms. Such a study may demonstrate that nonstenotic but
igure 6. Distribution of 18F-fluorodeoxyglucose (FDG) uptake in pa-
ients grouped by average plaque inflammation. Patients were grouped
ccording to the average amount of inflammation in their carotid speci-
ens and the average FDG uptake determined for each group. The ranges
ssigned to these groups reflect the levels of inflammation shown to be
mportant in previous histologic studies (14,20,21). The box plot shows
ean values (thick lines) and 25th and 75 percentile values (upper and
ower box boundaries). The length of the whiskers from the box
oundaries represents standard error of the mean. The mean FDG uptake
alue for each group was significantly different. T/B  target-to-
ackground ratio.
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FDG-PET Measures Vascular Inflammation in Humans November 7, 2006:1818–24nflamed plaques, which would not be identified for inter-
ention by the current stenosis-based screening method, are
ikely to cause events. If a link between FDG-PET imaging
nd events was established, this noninvasive measure could
e used to identify patients in need of intensified medical
herapy, carotid stenting, or CEA so that initial strokes
ight be prevented.
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